14 results
·
25ms
·
Sources: EU EUDAMED, US FDA
Filters
Status: Terminated
×
TLC-2000 Therapeutic Medical Laser System
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System, used for the temporary relief of knee pain.
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System - Product Usage: Indicated for the temporary relief of knee pain.
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System, Power Pack component TLC-2002 Used for the temporary relief of knee pain.
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System Power Pack, Model Number TLC-2002
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System
FDA Recall
Terminated
·Theralase Inc.·Product code NHN·September 26, 2019
TLC-2000 Therapeutic Medical Laser System, Power Pack component TLC-2002 Used for the temporary relief of knee pain.
FDA Enforcement
Class III
·Terminated·Theralase Inc.·December 11, 2019
TLC-2000 Therapeutic Medical Laser System
FDA Enforcement
Class III
·Terminated·Theralase Inc.·March 4, 2020
TLC-2000 Therapeutic Medical Laser System Power Pack, Model Number TLC-2002
FDA Enforcement
Class III
·Terminated·Theralase Inc.·March 4, 2020
TLC-2000 Therapeutic Medical Laser System
FDA Enforcement
Class III
·Terminated·Theralase Inc.·February 26, 2020
TLC-2000 Therapeutic Medical Laser System, used for the temporary relief of knee pain.
FDA Enforcement
Class III
·Terminated·Theralase Inc.·December 11, 2019
TLC-2000 Therapeutic Medical Laser System
FDA Enforcement
Class III
·Terminated·Theralase Inc.·March 4, 2020
TLC-2000 Therapeutic Medical Laser System - Product Usage: Indicated for the temporary relief of knee pain.
FDA Enforcement
Class III
·Terminated·Theralase Inc.·February 26, 2020